Dysbiosis of Gut Microbiota Contributes to the Development of Diabetes Mellitus
Authors:
- Xiong Zhong RuanXRXiong Zhong Ruan
- Stijn Section Editor(S): van der VeenSVStijn Section Editor(S): van der Veen
Open Access
- 1 December 2019
- journal article
- review article
- Published by Wolters Kluwer Health in Infectious Microbes and Diseases
- Vol. 1 (2) , 43-48
Abstract
Accumulating evidence has revealed that the composition of gut microbiota in patients with diabetes mellitus (DM) varies compared to those with healthy controls. The abnormal production and releases of metabolites derived from microbiota into the blood circulation contribute to the development of DM through the activation of multiple metabolic pathways, including trimethylamine N-oxide, short-chain fatty acids, lipopolysaccharide, aromatic amino acids, and their related metabolites. Therefore, the modulation of gut microbiota through dietary intervention, probiotics, broad-spectrum antibiotics, and fecal microbiota transplantation could be a potential therapeutic approach for DM. This review mainly summarized the complicated interactions of gut microbiota through its metabolites with DM.Keywords
This publication has 50 references indexed in Scilit:
- Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesityProceedings of the National Academy of Sciences of the United States of America, 2013
- Endotoxin increase after fat overload is related to postprandial hypertriglyceridemia in morbidly obese patientsJournal of Lipid Research, 2012
- Fecal bacteriotherapy for ulcerative colitis: Patients are ready, are we?Inflammatory Bowel Diseases, 2012
- The human microbiome: at the interface of health and diseaseNature Reviews Genetics, 2012
- Metabolic diseases and pro- and prebiotics: Mechanistic insightsNutrition & Metabolism, 2012
- CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4Cell, 2011
- Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbationProceedings of the National Academy of Sciences of the United States of America, 2010
- The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complexNature, 2009
- Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeabilityGut, 2009
- Gut Decontamination with Norfloxacin and Ampicillin Enhances Insulin Sensitivity in Mice2008